Nasopharyngeal detection of atypical bacteria by multiplex polymerase chain reaction panel in acutely ill children was associated with an increased risk of pneumonia
Acta Paediatrica · 2023
DOI: 10.1111/apa.16672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2023. Verfasst von Suvi Mattila und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland. Hauptthemen laut MEDLINE: Pneumonia, Bacterial, Respiratory Tract Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Lastentautien Tutkimussäätiö, Stiftelsen Alma och K. A. Snellman Säätiö, Suomen Lääketieteen Säätiö.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
We aimed to assess whether detection of respiratory bacteria by multiplex polymerase chain reaction (PCR) testing associates with clinical outcomes in acutely ill children.
Methods
This cross‐sectional study enrolled children under the age of 18 with a suspected respiratory infection treated in a paediatric emergency department of Oulu University Hospital, Finland from January 2015 through December 2015. Nasopharyngeal samples were routinely analysed for 16 respiratory viruses and later, after storage, analysed with a multiplex PCR panel for seven respiratory bacteria.
Results
At least one bacterial pathogen was detected in 600 out of the 1195 children (50%). The mean age was 3.3 (SD 3.7) years and 54% were boys. Atypical bacteria were associated with a risk of pneumonia (adjusted odds ratio [aOR] 14.1, 95% CI 3.98–50.1). Co‐detection of rhinovirus with Streptococcus pneumoniae was not associated with risk of pneumonia (aOR 2.39, 95% CI 0.78–7.30). Detection of Streptococcus pneumoniae , Haemophilus influenzae or both was not associated with the risk of hospital admission or prescription of antibiotics.
Conclusion
Nasopharyngeal detection of atypical bacteria in acutely ill children was associated with a markedly increased risk of pneumonia. The clinical utility of wide testing for other respiratory bacteria needs further evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland.
- Research Unit of Clinical Medicine and Medical Research Center Oulu, University of Oulu, Oulu, Finland.
- Department of Pediatrics and Adolescent Medicine, Kuopio University Hospital, Kuopio, Finland.
- University of Eastern Finland, Kuopio, Finland.
- Biocenter Oulu, University of Oulu, Oulu, Finland.
ORCID-Profile: Suvi Mattila, Niko Paalanne, Ulla Koskela, Terhi Tapiainen
Förderung
- Lastentautien Tutkimussäätiö
- Stiftelsen Alma och K. A. Snellman Säätiö
- Suomen Lääketieteen Säätiö
- Tutkijakoulu, Oulun Yliopiston
Zitieren
APA
Mattila, S., Sarlin, S., Heikkilä, R., Leinonen, E., Nurmi, V., Riikonen, J., Paalanne, N., Honkila, M., Huhtamäki, H., Pokka, T., Koskela, U., Renko, M., & Tapiainen, T. (2023). Nasopharyngeal detection of atypical bacteria by multiplex polymerase chain reaction panel in acutely ill children was associated with an increased risk of pneumonia. Acta Paediatrica. https://doi.org/10.1111/apa.16672
Vancouver
Mattila S, Sarlin S, Heikkilä R, Leinonen E, Nurmi V, Riikonen J, et al. Nasopharyngeal detection of atypical bacteria by multiplex polymerase chain reaction panel in acutely ill children was associated with an increased risk of pneumonia. Acta Paediatrica. 2023. doi:10.1111/apa.16672
BibTeX
@article{Mattila2023,
author = {Mattila, Suvi and Sarlin, Suvi and Heikkilä, Reetta and Leinonen, Emilia and Nurmi, Violetta and Riikonen, Jonni and Paalanne, Niko and Honkila, Minna and Huhtamäki, Heikki and Pokka, Tytti and Koskela, Ulla and Renko, Marjo and Tapiainen, Terhi},
title = {Nasopharyngeal detection of atypical bacteria by multiplex polymerase chain reaction panel in acutely ill children was associated with an increased risk of pneumonia},
journal = {Acta Paediatrica},
year = {2023},
doi = {10.1111/apa.16672}
}
EUVIMED